Chembio Diagnostics received Emergency Use Authorization for DPP COVID-19 s for IgG and IgM antibodies
On Apr. 15, 2020, Chembio Diagnostics announced receipt of FDA Emergency Use Authorization (EUA) for its DPP COVID-19…
Penn Medicine launched national component of global registry to track exposures and outcomes among providers who intubate
On Apr. 15, 2020, a team at the Perelman School of Medicine at the University of Pennsylvania launched…
Singapore researchers use NanoString’s nCounter to rapidly profile response of immune system to SARS-CoV-2 virus
On Apr. 15, 2020, NanoString Technologies announced the first publication utilizing the nCounter platform and its leading gene…
Philips detailed plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020
On Apr. 14, 2020, Royal Philips announced that it planed to double the production of its hospital ventilators…
AstraZeneca initiated CALAVI clinical trial with Calquence against COVID-19
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
Sanofi and GSK announced an unprecedented vaccine collaboration to fight COVID-19
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
Sinovac announced approval of human clinical trial for a vaccine candidate against COVID-19
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
Iceland provides picture of early spread of COVID-19 in population with cohesive public health response
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
Philips joined forces with Flex and Jabil to speed the production of hospital ventilators
On Apr. 14, 2020, Philips announced that it had joined forces with manufacturing partners Flex and Jabil to…
New Philips Respironics E30 ventilator introduced to help free up ICU units in wake of COVID-19
On Apr. 14, 2020, Philips announced its initiative to quickly scale production of its new Philips Respironics E30…
NantKwest and ImmunityBio announced therapeutics and vaccines for combatting COVID-19
On Apr. 14, 2020, NantKwest and ImmunityBio announced discussions with the FDA for vaccines and therapeutics to combat…
The Jackson Laboratory to provide expanded Coronavirus testing for Maine hospitals
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced additional coronavirus…
CHF Solutions announced COVID-19 patients teated with Aquadex Therapy for fluid management when access to dialysis machines limited or not available
On Apr. 14, 2020, CHF Solutions announced that physicians on the frontlines of treating patients with COVID-19 have…
Meridian Bioscience offered SARS-CoV-2 antigens for COVID-19 antibody tests
On Apr. 14, 2020, Meridian Bioscience announced it had launched a series of recombinant antigens for high sensitivity…
Alberta Hope COVID-19 study tested early treatment option
On Apr. 13, 2020, a province wide trial was announced that will investigate the effectiveness of hydroxychloroquine (HCQ)…
RedHill Biopharma reported the first two patients treated with opaganib at a leading hospital in Israel
On Apr. 13, 2020, RedHill Biopharma announced the first two patients were treated with opaganib at a leading…
Pluristem treated first COVID-19 patient in US under FDA single patient expanded access program
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
Bausch Health initiated VIRAZOLEï¾® (Ribavirin for inhalation solution, USP) clinical study in patients with COVID-19
On Apr. 13, 2020, Bausch Health announced it has initiated a clinical trial program in Canada evaluating an…
Emory University developed diagnostic antibody blood test to determine antibody-responses to COVID-19
On Apr. 13, 2020, Emory University developed a sensitive and specific diagnostic antibody, also known as serological tests,…
Mayo Clinic Laboratories launched serology testing in support of COVID-19 response
On Apr. 13, 2020, a new serology test from Mayo Clinic Laboratories that is used to identify the…
BD announced second FDA Emergency Use Authorization, CE Mark for new COVID-19 molecular diagnostic for global use
On Apr. 13, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
FDA authorized Athersys to initiate pvotal clinical trial evaluating MultiStemï¾® cell therapy in patients with COVID-19 induced ARDS
On Apr. 13, 2020, Athersys announced the FDA has authorized the Company to initiate a Phase 2/3 pivotal…
Aegis Sciences launched test for Coronavirus disease 2019 (COVID-19)
On Apr. 13, 2020, Aegis Sciences announced serving as a regional reference laboratory for COVID-19 testing being directed…
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
IHME released updated COVID-19 predictions for deaths and hospital use in the European Economic Area
On Apr. 10, 2020, the Institute for Health Metrics and Evaluation (IHME) released updated COVID-19 predictions for deaths…
Potential treatment for COVID-19 identified by BenevolentAI using artificial intelligence enters randomised clinical trial
On Apr. 10, 2020, BenevolentAI announced that baricitinib, which it had identified as a potential treatment for COVID-19,…
Data on 53 patients treated with investigational antiviral remdesivir through Compassionate Use Program published in NEJM
On Apr. 10, 2020, Gilead Sciences announced results from a cohort analysis of 53 patients hospitalized with severe…
Terumo BCT and Marker Therapeutics received FDA Emergency Use Authorization to treat acute respiratory failure in COVID-19 patients
On Apr. 10, 2020, Terumo BCT and Marker Therapeutics announced the FDA issued an Emergency Use Authorization (EUA)…
Eli Lilly began clinical testing of therapies for COVID-19
On Apr. 10, 2020, Eli Lilly announced it had entered into an agreement with the National Institute of…
NIH began clinical trial of hydroxychloroquine as potential therapy for COVID-19
On Apr. 9, 2020, the first participants were enrolled in the trial at Vanderbilt University Medical Center, Nashville,…